Chemical Structure (Levothyroxine 01)
Levothyroxine Sodium
Product Images NDC 52959-920
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 52959-920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (0.1 mg)
The text describes a medication, Levothyroxine, containing 100mcg per tablet and manufactured by Lannett. The Lot# mentioned is LEV105LH, with an expiration date of 01/11. The pill is yellow and round in shape. The directions for use suggest taking the medication as directed by a doctor or checking the product insert for usual dosage information. There are also multiple stock-keeping unit (SKUs) and lot numbers mentioned. The text recommends caution while handling and keeping the supplied medication. Finally, there is a mention of a comparative drug - Synthroid.*
Principal Display Panel (0.125 mg)
This is a description of a medication bottle containing 100 tablets of Levothyroxine 125mcg manufactured by Lannett. The lot number is LVNO5LH and it expires on 06/11. The medication is supposed to be taken as directed by a doctor. The pill is identified as a brown (tan) round tablet. It is compared to Synthroid 0527-1347-01. The text contains a warning to keep the medication out of reach of children and to store it at room temperature.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
